Chorda Pharma was founded to address the growing incidence of arthritis, diabetic neuropathy, sports injuries, and other ailments requiring long-term treatment to relieve pain. We are developing a pipeline of proprietary analgesics for managing chronic pain. Our medications are opioid-free, and offer safe and effective pain relief to millions of patients. Chorda's first drug is an over-the-counter (OTC) topical cream that will be available in 2023.
I frequently have soreness in my lower back while doing housework on the weekend. It’s irritated by being on my feet for too long and bending over to pick things up.
This Saturday my back was sore (a 4 on a scale of 1-10), and I didn’t want to vacuum or bend over at all. I applied a portion of the cream the size of my fingernail to my lower back.
The cream wasn’t greasy and soaked in immediately. Within a few minutes, the pain was gone and I was able to comfortably continue with my day.
I tried this again on Sunday with the same result.
This product worked for me! I am 66 years old and have been diagnosed by my orthopedic doctor as having bone spurs and severe arthritis in my left knee. On a 1-10 scale, applying Chorda’s cream 2x/day, within one week my pain level dropped from a 9 to a 5. And in less than 3 weeks, my pain level dropped even further to a 2.5 which allowed me to walk again with my dog 2-3 miles a day. Amazing stuff!
I recently had muscle spasms in my neck, shoulder, and the muscles over my shoulder blade. I applied the cream to the affected muscles and got relief. I continued to use the cream for several days when the muscles became sore. I feel that the cream relieved the intense pain and allowed the muscles to relax and heal.
I have a bulging disc and arthritis in my lower back. This cream has reduced my nagging pain so I can work easier.
The Virginia Innovation Partnership Corporation (VIPC) has notified Chorda Pharma that it will receive a grant from the Commonwealth Commercialization Fund (CCF) for the Commercialization of a Non-Opioid Topical Analgesic. The $75,000 award will be used to help fund the testing, pilot manufacturing, and marketing of Capsadyn™, which offers relief for patients suffering from chronic pain.
Download the full announcement.